key: cord-0843042-tfgcy1k2 authors: Brouqui, Philippe; Amrane, Sophie; Million, Matthieu; Cortaredona, Sébastien; Parola, Philippe; Lagier, Jean-Christophe; Raoult, Didier title: Asymptomatic hypoxia in COVID-19 is associated with poor outcome date: 2020-10-31 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.10.067 sha: a8624254a6ac3d26a8d194d77286702e2f744e92 doc_id: 843042 cord_uid: tfgcy1k2 Objectives Describe and evaluate the outcome of COVID patient without shortness of breath Design and methods We retrospectively collected data from COVID-19 patients diagnosed and cared for in Marseille France. We selected data from patients who had at admission, a low dose CT scanner, dyspnea status and oxygen saturation available. Blood-gas was analyzed in a sample subset of patients. Results Among 1712 patients with COVID-19 we report that 1107 (64.7%) do not complaint of a shortness of breath at admission. The LDCT scan showed signs compatible with pneumonia in 757/1,107 (68.4%) of patients without dyspnea. In a subset of patients who had underwent at least one blood gas analysis (n = 161) and presented without dyspnea at admission, 28.1% (27/96) presented with a hypoxemia/hypocapnia syndrome. Asymptomatic hypoxia was associated with a very poor outcome (33.3% were transferred to ICU and 25.9% died) Conclusion The absence of shortness of breath in old patient with co-morbidity merit medical attention and should not be considered as a good sign of wellbeing. The poor prognosis of asymptomatic hypoxia, highlight the severity of this mild clinical presentation. In these patient’s pulse oximetry is an important mean to predict the outcome along with news score and LDCT scanner. Recently, a new coronavirus named SARS-CoV-2 emerged in China at the end of December 2019 and rapidly spread throughout the world, producing millions of victims and J o u r n a l P r e -p r o o f several hundred thousand deaths (1) . The early descriptive reports of the clinical presentation of the disease resulting from SARS-CoV-2 infection, named COVID-19, revealed that a third of patients did not have dyspnea (2) . Shortness of breath has been reported in 18.7% of 1,099 patients hospitalized with COVID-19, many of whom showed an abnormal CT scan (86%) and received supplemental oxygen (41%) (3) . In patients with objective radiographic findings consistent with COVID-19 pneumonia, only 50% report shortness of breath (1) . Despite this accumulating knowledge, the criteria for clinical screening and care management in most countries, including France, are still based upon 3 symptoms: fever, cough and dyspnea. Asymptomatic patients are requested to self-isolate at home, while those that become symptomatic are invited to contact their health care provider (4) . However, some patients with COVID-19 deteriorate rapidly and seemingly without warning. For example, in Marseille, France, more than two thirds of patients hospitalized in intensive care units (ICUs) come directly from home or are admitted to the ICU after less than three days of standard ward hospitalization. Additionally, many patients who go on to develop respiratory failure experienced hypoxemia and hypocapnia without signs of respiratory distress, especially elderly patients. This is called "happy hypoxemia" or "silent hypoxemia" and was previously described in patients during the initial Wuhan outbreak (5) . The cause of this asymptomatic hypoxia is not yet clear. Anosmia-hyposmia has been reported as a frequent clinical sign in COVID (6) but whether SARS Cov2 access to the brain and contribute to the association between dyspnea and anosmia-hyposmia remained to be determined (7) . Some have links happy hypoxemia with the development of thrombi within the pulmonary vasculature (8) . The discrepancy between respiratory clinical signs and the pulmonary lesions observed with a low-dose computed tomography (LDCT) scanner were reported in the early epidemic by Chinese authors (1;2;9) but was not taken into account, and decisions based on home interviews of patients only considered dyspnea to justify hospital care. Massive test J o u r n a l P r e -p r o o f implementation and careful observation of positive patients, regardless of whether they were apparently symptomatic, allowed us to show that some patients who were classified as asymptomatic actually had hypoxia and others had lung damage visible on CT scan (10) . In this work, which is derived from a report based on a cohort of 3,737 patients , we wanted to focus on the relationship between dyspnea, hypoxemia and lung lesions identified in LDCT scans. We retrospectively collected data from the information system of our hospital related to COVID-19 patients diagnosed and cared for in the infectious disease institute (IHU Mediterranée Infection) in Marseille France from March 3rd until April 27th. All patient care were diagnosed by PCR of a nasopharyngeal sample and were over 18 y-o (10;11). We selected data from patients who had in their record at admission, all of the following items: a low dose CT Scanner, dyspnea status and oxygen saturation available (1,712 patients). Bloodgas were analyzed in a sample subset (161 patients). Dyspnea is a subjective sign which was recorded at interview and was defined as shortness of breath. O2 desaturation was defined as SaO2<=95%. A low-dose CT scanner was proposed for all patients as soon as possible after admission when possible, and radiological lesions were classified into four categories: normal, minimal grade 1, intermediate grade 2 or severe grade 3 (12) . Hypoxemia was defined as pO2_mmHg<= 80, and hypocapnia as pCO2_mmHg<=35. Demographics, chronic conditions (cancer, diabetes mellitus, chronic heart disease, hypertension, chronic respiratory disease and obesity), concomitant medication, and signs and symptoms, including fever, cough, anosmia, ageusia, dyspnea, oxygen saturation, and blood gas analysis were extracted from the hospital information system (10) . Severity was assessed using the national early warning score adapted to COVID-19 patients (NEWS-2) (12). Statistics Categorical variables are presented as n (%). We used Chi-squared test, Fisher's exact test, univariate logistic regressions and estimated odds ratios (ORs) with 95% confidence intervals (CIs) to compare differences between patients with dyspnea and patients without dyspnea. To compare the prognosis performance of the LDCT scanner score and O2 saturation on clinical outcomes (transfer to ICU/death) among patients with no dyspnea, we performed multivariate logistic regressions. Models were adjusted on the following covariates: age, sex, time from symptom onset to admission, comorbidities (cancer, diabetes mellitus, cardiac diseases, hypertension, chronic respiratory diseases, obesity) and clinical classification at inclusion (NEWS score). Four separate models were carried out. In the reference model (model A), all covariates previously listed were included. In Model B, we added to this list the LDCT scanner severity score. In model C, we added O2 saturation. Model D included both O2 saturation and the LDCT scanner severity. We calculated the Akaike information criterion (AIC) and computed the C-statistic for each model. The C-statistic is equal to the area under the receiver operating characteristic (ROC) curve and ranges from 0.5 to 1. A two-sided α value of less than 0·05 was considered statistically significant. To investigate associations between clinical data, biological data, radiological data and clinical outcomes (death and/or ICU stay), we performed univariate logistic regressions and Principal Component Analysis (PCA) in a subset of 161 patients who had underwent at least one blood gas analysis. Hierarchical Clustering on Principal Components (HCPC) was performed to identify clusters of patients. Analyses were carried out using SAS 9.4 statistical software (SAS Institute, Cary, NC). PCA and HCPC were performed using R Statistical Software and the FactoMineR package (13) . had an O2 sat ≤90. Compared with patients without dyspnea, oxygen saturation was significantly worse in patients with dyspnea ( Table 2) . Among the 1,107 without dyspnea, those which LDCT grade 2 and 3 lesions had significantly higher odds of having a poor clinical outcome during follow-up (OR 95% CI: 9.45; 3.02-29.62) ( Table 3) . Compared to the model with O2 sat (OR 95% CI: 0.78; 0.65-0.93), the model with LDCT scan score achieved a better goodness-of-fit (lower AIC). In the subset of patients who had underwent at least one blood gas analysis (n=161) and presented without dyspnea at admission, 28.1% (27/96) presented with a hypoxemia/hypocapnia syndrome defining asymptomatic hypoxia Figure 2 . HCPC analysis distinguished three clusters. Hypoxemia/hypocapnia syndrome (yellow dots) was clustered with death/ICU, elevated NEWS score, age, male and elevated D-dimers. Hypoxemia/hypocapnia was associated with aging, male, and chronic heart disease but not with diabetes mellitus. Hypoxemia/hypercapnia (33%) clustered with favorable outcome and was associated with younger age. Hyperoxemia/ hypocapnia (22%) was associated with women and younger age. Hyperoxemia/hypercapnia (15%) was surprisingly associated with cancer (Figure 3, Table 4 ). Hypoxemia/hypocapnia syndrome was strongly associated with death/ICU (OR 95% CI: 4.37; 2.12-9.03) (p<0.0001) and elevated D-dimers >2.5 mg/l (OR 95% CI: 6.26; 1.99-19.75) (p=0.002). In patient with COVID 19 dyspnea is linked to poor outcome and merit attention and urgent care. However, it is important to underling that among 1712 patients with COVID-19, 64.7% (1107) do not complaint of shortness of breath at admission and that 23 of them were transferred to ICU and /or died highlighting the severity of this clinical presentation. In these patients, News score, LDCT of the thorax and pulse oximetry are important means to predict death. Moreover, among patient without dyspnea 28.1% presented with hypoxemia/hypocapnia syndrome (happy or silent hypoxemia) which was also strongly associated with a poor outcome. Due to inclusion criteria, our studied population was significantly more severe and had a longer time from symptom onset to admission suggesting a selection bias. Consequently our results cannot be extrapolated to the whole population of patients with COVID-19. To the best of our knowledge, this work is the most comprehensive comparison of dyspneic and non-dyspneic COVID-19 patients and their blood gas analysis results and lung lesion findings visualized on a low-dose CT scan. Asymptomatic hypoxia has only been reported recently in COVID-19 patients (5, 7) . Hypoxia with accompanying hypocapnia generates no sensation of breathlessness, on the contrary, it may feel comfortable (14) , and COVID-19 patients do not necessarily appear dyspneic until late in the course of the disease J o u r n a l P r e -p r o o f (5) . Physicians treating COVID-19 patients, including us, have reported caring for patients who presented well and then suddenly, within a few hours, progressed to severe respiratory distress (14) . The subjective sensation of dyspnea is driven by the respiratory center in our brain that is sensitive to increased CO2 and to a lesser degree, decreased O2 (7). Our respiratory center can become desensitized as we age and from chronic conditions such as diabetes (15) . Patients with diabetes were noted to be 1.8 times more likely to have an impaired ability to perceive respirations than nondiabetic controls. Therefore, it was suggested that patients who are presenting with silent hypoxemia are most likely the elderly and those with chronic diseases and consequently the poorest outcomes. In our cohort, age but not diabetes was associated with dyspnea and hypoxemia. While pulse oximetry is underestimating true pO2_mmHg, in patient feeling comfortable at admission we show that it predicts well the outcome. As consequence in patient with COVID but without shortness of breath, pulse oximetry should be added to the News score and to LDCT to monitor the care. The incidence of thrombotic complications in ICU patients with COVID-19 infection is remarkably high (16) . This has been well established by a recent study of necropsied patients, which reported that although the predominant patterns of lung lesions are diffuse alveolar, damage associated with the presence of platelet-fibrin thrombi in small arterial vessels is consistent with coagulopathy and appears extremely common (17) . Hypoxemia and elevated D-dimers strongly suggest that the resulting lung damage is due in part to arterial microemboli and might explain the severity of clinical presentation and the subsequent death. These findings reinforce the recommendation to apply thrombosis prophylaxis in these patients (16) . It appears now clear that dyspnea is not a key criterion of initial severity in patients with COVID-19. As recommended by the CDC and many other heath policies throughout the J o u r n a l P r e -p r o o f world, "Patients with a mild clinical presentation (absence of viral pneumonia and hypoxia) may not initially require hospitalization, and many patients will be able to manage their illness at home" (4) . We believe that it is necessary to systematically ask for shortness of breath that is a subjective sensation not related with respiratory frequency and very frequently reported. Among patients feeling well and without dyspnea, a third (28.1%) might present with hypoxemia at admission. This absence of shortness of breath merit medical attention and it should not be considered as a good sign of wellbeing. We suggest that for these patients with "a mild clinical presentation" it is particularly important to achieve in a regular basis oxygen saturation with pulse oximetry completed with blood gas analysis if necessary, to allow early diagnosis of asymptomatic hypoxia and a more appropriate care to reduce the poor outcome. This study was supported by the National Research Agency under the program «Investissements d'avenir », reference ANR-10-IAHU-03. The noninterventional retrospective nature of the study was approved by our institutional review board committee (Mediterranée Infection N°: 2020-021). According to European General Data Protection Regulation No 2016/679, patients were informed of the potential use of their medical data and that they could refuse. The analysis of collected data followed the reference methodology MR-004 registered on N° MR 5010010520 in the AP-HM register. None of the authors report a conflict of interest that might interfere with the manuscript contents Declaration of interests J o u r n a l P r e -p r o o f The authors declare that they haveno known competingfinancialinterestsor personal relationships that could have appeared to influence the work reported in this paper. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical Characteristics of Coronavirus Disease 2019 in China Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19) : clinical managment and treatment Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China Olfactory and gustative disorders for the diagnosis of COVID-19 Why COVID-19 Silent Hypoxemia Is Baffling to Physicians The mystery of the pandemic's 'happy hypoxia The progress of 2019 Novel Coronavirus (2019-nCoV) event in China Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province FactoMineR: An R Package for Multivariate Analysis COVID-19 with silent hypoxemia Diminished perception of inspiratoryresistive loads in insulin-dependent diabetics Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study The English language in this text was edited by American Journal Experts.